Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Porphyria variegata
(2001): Grieco A+, Eur J Gastroenterol Hepatol 13(8), 973
Pseudolymphoma
(2006): Alvarez-Ruiz S+, Actas Dermosifiliogr 97(1), 43
(2001): Cogrel O+, Br J Dermatol 144(6), 1235
(2001): Miranda-Romero A+, Cutis 67(1), 47
(1999): Saeki H+, JDermatol26, 329
(1998): d’Incan M+, Ann Dermatol Venereol 125, 52
(1998): Nathan D+, JAmAcadDermatol38, 806
(1997): Kim ST+, Korea, American Academy of Dermatology
Meeting (SF), Poster #82
(1997): Paramesh H+, Indian Pediatr 34, 829
(1996): Callot V+, Arch Dermatol 132, 1315
(1995): Magro CM+, JAmAcadDermatol32, 419
(1993): Rondas AA+, Ned Tijdschr Geneeskd (Dutch) 137, 1258
(1993): Sigal M+, Ann Dermatol Venereol (French) 120, 175
(1991): Rijlaarsdam U+, JAmAcadDermatol24(2), 216
(1990): Sinnige HAM+, J Intern Med 227, 355
(1986): Yates P+, J Clin Pathol 39, 1224
(1984): Shuttleworth D+, Clin Exp Dermatol 9, 424
Rhabdomyolysis
(1992): Zele I+, Minerva Med 83(12), 847
Serum sickness
(1993): Igarashi M+, Int Arch Allergy Immunol 100, 378
Thrombophlebitis
CARBENICILLIN
Trade names: Carbecin; Carbelin; Geocillin (Pfizer); Geopen;
Pyopen
Indications: Urinary tract infections
Category: Antibiotic, penicillin
Half-life: 1.0–1.5 hours
Clinically important, potentially hazardous interactions
with: anticoagulants, ceftobiprole, cyclosporine, demeclocycline,
doxycycline, gentamicin, imipenem/cilastatin, methotrexate,
minocycline, oxytetracycline, tetracycline
Reactions
Skin
Allergic reactions (sic)
(1994): Pleasants RA+, Chest 106, 1124 (in patients with cystic
fibrosis)
Angioedema
Bullous dermatitis
Edema
Erythema multiforme
Erythema nodosum
Exanthems
Exfoliative dermatitis
Hematomas
Hemorrhage
Jarisch–Herxheimer reaction
Pruritus
Purpura
Rash (sic) (